DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Broad protection against Invasive fungal disease from a nanobody targeting the active site of fungal β-1,3-glucanosyltransferases
9 figures.-- Supplementary information available.-- Atomic coordinate files and structure factors have been deposited in the Protein DataBank (PDB) with accession codes 8PE2 (dGel4-Nb3 complex) and 8PE1 (dGel4-Nb4 complex). Data collection and refinement statistics are presented in Table S2 of the supplementary information., Invasive fungal disease accounts for about 3.8 million deaths annually, an unacceptable rate that urgently prompts the discovery of new knowledge-driven treatments. We report the use of camelid single-domain nanobodies (Nbs) against fungal β-1,3-glucanosyltransferases (Gel) involved in β-1,3-glucan transglycosylation. Crystal structures of two Nbs with Gel4 from Aspergillus fumigatus revealed binding to a dissimilar CBM43 domain and a highly conserved catalytic domain across fungal species, respectively. Anti-Gel4 active site Nb3 showed significant antifungal efficacy in vitro and in vivo prophylactically and therapeutically against different A. fumigatus and Cryptococcus neoformans isolates, reducing the fungal burden and disease severity, thus significantly improving immunocompromised animal survival. Notably, C. deneoformans (serotype D) strains were more susceptible to Nb3 and genetic Gel deletion than C. neoformans (serotype A) strains, indicating a key role for β-1,3-glucan remodelling in C. deneoformans survival. These findings add new insight about the role of β-1,3-glucan in fungal biology and demonstrate the potential of nanobodies in targeting fungal enzymes to combat invasive fungal diseases., We thank ARAID, CIBERINFEC (CB21-13-0087 and CB21/13/00105, IS Carlos III, Spain), the Slovak Grant Agency for Science (VEGA), Ministry of Science, Innovation and Universities and Agencia Estatal de Investigación, Spain (BIO2016-79289-P, PID2019-105223GB-I00/AEI/10.13039/501100011033, PID2022-136888NB-I00/AEI/10.13039/501100011033, CTQ2013-44367-C2-2-P, BFU2016-75633-P, PID2019-105451GB-I00, SAF2017-83120-C2-1-R, PID2020-113963RB-I00, PID2020-114546RB-I00 and PID2022-136362NB-I00), Comunidad Autónoma de Madrid (CAM) (S2017/BMD3691-InGEMICS-CM), ASPANOA and Gobierno de Aragón (B29_17R, E34_R17, LMP58_18 and LMP139_21) with FEDER (2014-2020) funds for ‘Building Europe from Aragón’ for financial support. The research leading to these results has also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement No. 283570 and BIOSTRUCTX_5186). M.A. was supported by a post-doctoral fellowship “Juan de la Cierva-formación” (FJCI-2017-31629), J.C.-L. and I.G.-B. were supported by FPI fellowships from Ministerio de Ciencia e Innovación, and J.M.-L. and S.R. by a predoctoral fellowship from Gobierno de Aragón. We thank a crowdfunding initiative through the platform Precipita (Nanofungi) for funding support., Peer reviewed
Project:
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 BIO2016-79289-P
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2019-105223GB-I00
,
AEI / Ingeniería Microbiana Salud y Calidad de Vida PID2022-136888NB-I00
,
MINECO / FP7 CTQ2013-44367-C2-2-P
,
MINECO / FP7 BFU2016-75633-P
,
CAM S2017
,
EC 283570
,
EC BIOSTRUCTX_5186
View at: http://hdl.handle.net/10261/365916